Jianjun ZOU,Yaling HUANG,Tonghuan HU,Xiaoyu ZHU,Jun FENG,Changyong YANG,Chen ZONG,Guoqing CAO
申请号：
US16334251
公开号：
US20190224189A1
申请日:
2017.09.22
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Provided is a method of treating cancer with a tyrosine-kinase inhibitor. In particular, provided is a method of treating cancer containing a mutated epidermal growth factor receptor (EGFR) with compound A, or a pharmaceutically acceptable salt thereof, preferably a maleate or dimaleate salt of compound A.
